IRIS Accounts Production v25.1.0.734 08231922 Board of Directors 1.10.23 30.9.24 30.9.24 false true false false true false Ordinary 1.00000 A Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh082319222023-09-30082319222024-09-30082319222023-10-012024-09-30082319222022-09-30082319222022-10-012023-09-30082319222023-09-3008231922ns15:EnglandWales2023-10-012024-09-3008231922ns14:PoundSterling2023-10-012024-09-3008231922ns10:Director12023-10-012024-09-3008231922ns10:PrivateLimitedCompanyLtd2023-10-012024-09-3008231922ns10:SmallEntities2023-10-012024-09-3008231922ns10:AuditExempt-NoAccountantsReport2023-10-012024-09-3008231922ns10:SmallCompaniesRegimeForDirectorsReport2023-10-012024-09-3008231922ns10:SmallCompaniesRegimeForAccounts2023-10-012024-09-3008231922ns10:FullAccounts2023-10-012024-09-3008231922ns10:OrdinaryShareClass12023-10-012024-09-3008231922ns10:OrdinaryShareClass22023-10-012024-09-3008231922ns10:Director22023-10-012024-09-3008231922ns10:RegisteredOffice2023-10-012024-09-3008231922ns5:CurrentFinancialInstruments2024-09-3008231922ns5:CurrentFinancialInstruments2023-09-3008231922ns5:Non-currentFinancialInstruments2024-09-3008231922ns5:Non-currentFinancialInstruments2023-09-3008231922ns5:ShareCapital2024-09-3008231922ns5:ShareCapital2023-09-3008231922ns5:CapitalRedemptionReserve2024-09-3008231922ns5:CapitalRedemptionReserve2023-09-3008231922ns5:RetainedEarningsAccumulatedLosses2024-09-3008231922ns5:RetainedEarningsAccumulatedLosses2023-09-3008231922ns5:FurnitureFittings2023-09-3008231922ns5:FurnitureFittings2023-10-012024-09-3008231922ns5:FurnitureFittings2024-09-3008231922ns5:FurnitureFittings2023-09-3008231922ns5:WithinOneYearns5:CurrentFinancialInstruments2024-09-3008231922ns5:WithinOneYearns5:CurrentFinancialInstruments2023-09-300823192212024-09-300823192222023-09-3008231922ns5:Non-currentFinancialInstrumentsns5:MoreThanFiveYears2024-09-3008231922ns5:Non-currentFinancialInstrumentsns5:MoreThanFiveYears2022-09-3008231922ns5:WithinOneYear2024-09-3008231922ns5:WithinOneYear2023-09-3008231922ns5:BetweenOneFiveYears2024-09-3008231922ns5:BetweenOneFiveYears2023-09-3008231922ns5:AllPeriods2024-09-3008231922ns5:AllPeriods2023-09-3008231922ns10:OrdinaryShareClass12024-09-3008231922ns10:OrdinaryShareClass22024-09-30
REGISTERED NUMBER: 08231922 (England and Wales)












UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30 SEPTEMBER 2024

FOR

REMSERVE MEDICAL SUPPLIES LIMITED

REMSERVE MEDICAL SUPPLIES LIMITED (REGISTERED NUMBER: 08231922)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


REMSERVE MEDICAL SUPPLIES LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 30 SEPTEMBER 2024







DIRECTORS: Mr C Wingfield
Mrs K Hardwick





REGISTERED OFFICE: Edwinstowe House
Edwinstowe
Mansfield
Nottinghamshire
NG21 9PR





REGISTERED NUMBER: 08231922 (England and Wales)





ACCOUNTANTS: Gibson Booth Limited
12 Victoria Road
Barnsley
South Yorkshire
S70 2BB

REMSERVE MEDICAL SUPPLIES LIMITED (REGISTERED NUMBER: 08231922)

BALANCE SHEET
30 SEPTEMBER 2024

30.9.24 30.9.23
Notes £    £    £   
FIXED ASSETS
Tangible assets 4 9,989 6,900

CURRENT ASSETS
Stocks 442,800 436,958
Debtors 5 306,556 195,894
Cash at bank and in hand 634,783 456,183
1,384,139 1,089,035
CREDITORS
Amounts falling due within one year 6 267,438 186,005
NET CURRENT ASSETS 1,116,701 903,030
TOTAL ASSETS LESS CURRENT LIABILITIES 1,126,690 909,930

CREDITORS
Amounts falling due after more than
one year

7

(9,071

)

(39,066

)

PROVISIONS FOR LIABILITIES (1,016 ) (1,016 )
NET ASSETS 1,116,603 869,848

CAPITAL AND RESERVES
Called up share capital 9 6 6
Capital redemption reserve 5 5
Retained earnings 1,116,592 869,837
SHAREHOLDERS' FUNDS 1,116,603 869,848

REMSERVE MEDICAL SUPPLIES LIMITED (REGISTERED NUMBER: 08231922)

BALANCE SHEET - continued
30 SEPTEMBER 2024


The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 September 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 September 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 10 April 2025 and were signed on its behalf by:





Mr C Wingfield - Director


REMSERVE MEDICAL SUPPLIES LIMITED (REGISTERED NUMBER: 08231922)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2024

1. STATUTORY INFORMATION

Remserve Medical Supplies Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The financial statements are presented in sterling which is the functional currency of the company and rounded to the nearest pound.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Significant judgements and estimates
No judgements have been made in the process of applying the below accounting policies that have had the most significant effect on amounts recognised in the financial statements.

There are no key assumptions concerning the future and other key sources of estimation uncertainty at the reporting date that have a significant risk of causing material adjustment to the carrying amounts of assets and liabilities within the next financial year.

Turnover
Turnover is measured at the fair value of the consideration received or receivable net of VAT and trade discounts.

Turnover from the sale of medical equipment is recognised when significant risks and rewards of ownership of the goods have transferred to the buyer, the amount of turnover can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the company and the costs incurred or to be incurred in respect of the transaction can be measured reliably. This is usually on dispatch of the goods.

Tangible fixed assets
Tangible fixed assets are stated at cost (or deemed cost) or valuation less accumulated depreciation and accumulated impairment losses. Cost includes costs directly attributable to making the asset capable of operating as intended.

Depreciation is provided on all tangible fixed assets, at rates calculated to write off the cost, less estimated residual value, of each asset on a systematic basis over its expected useful life as follows:

Fixtures and fittings - 25% reducing balance
Computer equipment - 33% straight line

REMSERVE MEDICAL SUPPLIES LIMITED (REGISTERED NUMBER: 08231922)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 SEPTEMBER 2024

2. ACCOUNTING POLICIES - continued

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving stock.

Cost is calculated using the first-in, first-out method and includes all purchase, transport and handling costs in bringing stocks to their present location and condition.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 9 (2023 - 8 ) .

REMSERVE MEDICAL SUPPLIES LIMITED (REGISTERED NUMBER: 08231922)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 SEPTEMBER 2024

4. TANGIBLE FIXED ASSETS
Fixtures
and
fittings
£   
COST
At 1 October 2023 26,638
Additions 8,504
At 30 September 2024 35,142
DEPRECIATION
At 1 October 2023 19,738
Charge for year 5,415
At 30 September 2024 25,153
NET BOOK VALUE
At 30 September 2024 9,989
At 30 September 2023 6,900

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.9.24 30.9.23
£    £   
Trade debtors 277,361 180,911
Other debtors 26,148 5,358
Prepayments 3,047 9,625
306,556 195,894

REMSERVE MEDICAL SUPPLIES LIMITED (REGISTERED NUMBER: 08231922)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 SEPTEMBER 2024

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.9.24 30.9.23
£    £   
Other loans 24,000 24,000
Trade creditors 28,486 52,547
Corporation tax 109,539 54,340
Social security and other taxes 1,619 (5,657 )
VAT 69,793 50,018
Other creditors 1,348 1,107
Directors' current accounts 30,903 7,950
Accruals and deferred income 1,750 1,700
267,438 186,005

7. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR
30.9.24 30.9.23
£    £   
Other loans - 1-2 years 9,071 24,000
Other loans - 2-5 years - 15,066
9,071 39,066

8. LEASING AGREEMENTS

Minimum lease payments under non-cancellable operating leases fall due as follows:
30.9.24 30.9.23
£    £   
Within one year 2,662 2,904
Between one and five years - 9,930
2,662 12,834

9. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 30.9.24 30.9.23
value: £    £   
5 Ordinary £1 5 5
1 A Ordinary £1 1 1
6 6